I'm Stephen Strom.
I'm a Torsten och Ragnar Soderberg
Professor of Cell Transplantation
Regenerative Medicine at
the Department of Laboratory
and Medicine, Karolinska Institute
in the Division of Pathology.
I'm going to talk today
about the Human Hepatocyte
Isolation for Clinical Transplants.
Our group is the first to transplant
human hepatocytes into patients
with liver disease in America, and
my laboratory was the first one
to be approved by the FDA
for isolation of hepatocytes
transplants so we'd like
to share this experience with you.
We've collected about 2,000
livers for hepatocyte isolation,
so we have some considerable
experience in this area.
Although I don't believe there's
any conflict of interest,
I put this slide in there.
I am a stockholder in Stemnion,
which is a stem cell company
interested in placental stem
cells and Yecuris, which
is a company interested in making
mice with humanized livers for drug
discovery and drug
But none of the products
from Yecuris or Stemnion
are used in any of these slides
I'm going to present today.
So what we're interested in
is really this field called
and this is
a cellular therapy
for liver disease.